{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T21:54:57Z","timestamp":1769637297564,"version":"3.49.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T00:00:00Z","timestamp":1715385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T00:00:00Z","timestamp":1715385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18H02842"],"award-info":[{"award-number":["18H02842"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21H02952"],"award-info":[{"award-number":["21H02952"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K06870"],"award-info":[{"award-number":["21K06870"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K17383"],"award-info":[{"award-number":["20K17383"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22J40054"],"award-info":[{"award-number":["22J40054"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["15K19545"],"award-info":[{"award-number":["15K19545"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008673","name":"Yasuda Memorial Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008673","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008667","name":"SENSHIN Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1038\/s41375-024-02276-w","type":"journal-article","created":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T12:01:36Z","timestamp":1715428896000},"page":"1275-1286","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["TIF1\u03b2 activates leukemic transcriptional program in HSCs and promotes BCR::ABL1-induced myeloid leukemia"],"prefix":"10.1038","volume":"38","author":[{"given":"Mariko","family":"Morii","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6119-1259","authenticated-orcid":false,"given":"Sho","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihoko","family":"Iimori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3879-7046","authenticated-orcid":false,"given":"Takako","family":"Yokomizo-Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1683-4443","authenticated-orcid":false,"given":"Ai","family":"Hamashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7485-4450","authenticated-orcid":false,"given":"Jie","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiho","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"Tasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimi","family":"Araki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2318-5987","authenticated-orcid":false,"given":"Goro","family":"Sashida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,11]]},"reference":[{"key":"2276_CR1","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nrc1567","volume":"5","author":"R Ren","year":"2005","unstructured":"Ren R. Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat Rev Cancer. 2005;5:172\u201383.","journal-title":"Nat Rev Cancer"},{"key":"2276_CR2","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1056\/NEJMra2113347","volume":"386","author":"R Fo\u00e0","year":"2022","unstructured":"Fo\u00e0 R, Chiaretti S. Philadelphia Chromosome\u2013Positive Acute Lymphoblastic Leukemia. N Engl J Med. 2022;386:2399\u2013411.","journal-title":"N Engl J Med"},{"key":"2276_CR3","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nm0596-561","volume":"2","author":"BJ Druker","year":"1996","unstructured":"Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S, et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med. 1996;2:561\u20136.","journal-title":"Nat Med"},{"key":"2276_CR4","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1056\/NEJMoa062867","volume":"355","author":"BJ Druker","year":"2006","unstructured":"Druker BJ, Guilhot F, O\u2019Brien SG, Gathmann I, Kantarjian H, Gattermann N, et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med. 2006;355:2408\u201317.","journal-title":"N Engl J Med"},{"key":"2276_CR5","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1038\/leu.2016.115","volume":"30","author":"S Sau\u00dfele","year":"2016","unstructured":"Sau\u00dfele S, Richter J, Hochhaus A, Mahon FX. The concept of treatment-free remission in chronic myeloid leukemia. Leukemia. 2016;30:1638\u201347.","journal-title":"Leukemia"},{"key":"2276_CR6","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3324\/haematol.2014.116954","volume":"100","author":"E Brissot","year":"2015","unstructured":"Brissot E, Labopin M, Beckers MM, Soci\u00e9 G, Rambaldi A, Volin L, et al. Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with philadelphia chromosome positive acute lymphoblastic leukemia. Haematologica. 2015;100:392\u20139.","journal-title":"Haematologica"},{"key":"2276_CR7","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.ccell.2020.03.006","volume":"37","author":"TP Braun","year":"2020","unstructured":"Braun TP, Eide CA, Druker BJ. Response and Resistance to BCR-ABL1-Targeted Therapies. Cancer Cell. 2020;37:530\u201342.","journal-title":"Cancer Cell"},{"key":"2276_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-017-0374-4","volume":"24","author":"P Czerwi\u0144ska","year":"2017","unstructured":"Czerwi\u0144ska P, Mazurek S, Wiznerowicz M. The complexity of TRIM28 contribution to cancer. J Biomed Sci. 2017;24:1\u201314.","journal-title":"J Biomed Sci"},{"key":"2276_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12082094","volume":"12","author":"RM McAvera","year":"2020","unstructured":"McAvera RM, Crawford LJ. TIF1 proteins in genome stability and cancer. Cancers. 2020;12:1\u201318.","journal-title":"Cancers"},{"key":"2276_CR10","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1101\/gad.973302","volume":"16","author":"DC Schultz","year":"2002","unstructured":"Schultz DC, Ayyanathan K, Negorev D, Maul GG, Rauscher FJ. SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes Dev. 2002;16:919\u201332.","journal-title":"Genes Dev"},{"key":"2276_CR11","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/nature08858","volume":"464","author":"T Matsui","year":"2010","unstructured":"Matsui T, Leung D, Miyashita H, Maksakova I, Miyachi H, Kimura H, et al. Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET. Nature. 2010;464:927\u201331.","journal-title":"Nature"},{"key":"2276_CR12","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1242\/dev.127.13.2955","volume":"127","author":"F Cammas","year":"2000","unstructured":"Cammas F, Mark M, Doll\u00e9 P, Dierich A, Chambon P, Losson R. Mice lacking the transcriptional corepressor TIF1\u03b2 are defective in early postimplantation development. Development. 2000;127:2955\u201363.","journal-title":"Development"},{"key":"2276_CR13","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/ni.2293","volume":"13","author":"S Chikuma","year":"2012","unstructured":"Chikuma S, Suita N, Okazaki IM, Shibayama S, Honjo T. TRIM28 prevents autoinflammatory T cell development in vivo. Nat Immunol. 2012;13:596\u2013603.","journal-title":"Nat Immunol"},{"key":"2276_CR14","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.4049\/jimmunol.2001003","volume":"206","author":"S Chikuma","year":"2021","unstructured":"Chikuma S, Yamanaka S, Nakagawa S, Ueda MT, Hayabuchi H, Tokifuji Y, et al. TRIM28 Expression on Dendritic Cells Prevents Excessive T Cell Priming by Silencing Endogenous Retrovirus. J Immunol. 2021;206:1528\u201339.","journal-title":"J Immunol"},{"key":"2276_CR15","doi-asserted-by":"publisher","first-page":"17871","DOI":"10.1074\/jbc.M112.437756","volume":"288","author":"S Kubota","year":"2013","unstructured":"Kubota S, Fukumoto Y, Aoyama K, Ishibashi K, Yuki R, Morinaga T, et al. Phosphorylation of KRAB-associated protein 1 (KAP1) at Tyr-449, Tyr-458, and Tyr-517 by nuclear tyrosine kinases inhibits the association of KAP1 and Heterochromatin Protein 1 a (HP1a) with heterochromatin. J Biol Chem. 2013;288:17871\u201383.","journal-title":"J Biol Chem"},{"key":"2276_CR16","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1172\/JCI29544","volume":"117","author":"CD Venkov","year":"2007","unstructured":"Venkov CD, Link AJ, Jennings JL, Plieth D, Inoue T, Nagai K, et al. A proximal activator of transcription in epithelial-mesenchymal transition. J Clin Investig. 2007;117:482\u201391.","journal-title":"J Clin Investig"},{"key":"2276_CR17","doi-asserted-by":"publisher","first-page":"11400","DOI":"10.1073\/pnas.93.21.11400","volume":"93","author":"DS Ory","year":"1996","unstructured":"Ory DS, Neugeboren BA, Mulligan RC. A stable human-derived packaging cell line for production of high titer retrovirus\/vesicular stomatitis virus G pseudotypes. Proc Natl Acad Sci USA. 1996;93:11400\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2276_CR18","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1158\/0008-5472.CAN-19-3167","volume":"80","author":"T Yokomizo-Nakano","year":"2020","unstructured":"Yokomizo-Nakano T, Kubota S, Bai J, Hamashima A, Morii M, Sun Y, et al. Overexpression of RUNX3 represses RUNX1 to drive transformation of myelodysplastic syndrome. Cancer Res. 2020;80:2523\u201336.","journal-title":"Cancer Res"},{"key":"2276_CR19","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/nmeth.4396","volume":"14","author":"MR Corces","year":"2017","unstructured":"Corces MR, Trevino AE, Hamilton EG, Greenside PG, Sinnott-Armstrong NA, Vesuna S, et al. An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues. Nat Methods. 2017;14:959\u201362.","journal-title":"Nat Methods"},{"key":"2276_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-02866-0","volume":"9","author":"T Hayashi","year":"2018","unstructured":"Hayashi T, Ozaki H, Sasagawa Y, Umeda M, Danno H, Nikaido I. Single-cell full-length total RNA sequencing uncovers dynamics of recursive splicing and enhancer RNAs. Nat Commun. 2018;9:619.","journal-title":"Nat Commun"},{"key":"2276_CR21","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jare.2020.04.016","volume":"24","author":"SQ Li","year":"2020","unstructured":"Li SQ, Liu J, Zhang J, Wang XL, Chen D, Wang Y, et al. Transcriptome profiling reveals the high incidence of hnRNPA1 exon 8 inclusion in chronic myeloid leukemia. J Adv Res. 2020;24:301\u201310.","journal-title":"J Adv Res"},{"key":"2276_CR22","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"JN Weinstein","year":"2013","unstructured":"Weinstein JN, Collisson EA, Mills GB, Shaw KRM, Ozenberger BA, Ellrott K, et al. The cancer genome atlas pan-cancer analysis project. Nat Genet. 2013;45:1113\u201320.","journal-title":"Nat Genet"},{"key":"2276_CR23","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.ccr.2011.10.012","volume":"20","author":"D Reynaud","year":"2011","unstructured":"Reynaud D, Pietras E, Barry-Holson K, Mir A, Binnewies M, Jeanne M, et al. IL-6 Controls Leukemic Multipotent Progenitor Cell Fate and Contributes to Chronic Myelogenous Leukemia Development. Cancer Cell. 2011;20:661\u201373.","journal-title":"Cancer Cell"},{"key":"2276_CR24","doi-asserted-by":"publisher","first-page":"6055","DOI":"10.1038\/onc.2015.54","volume":"34","author":"KM Lee","year":"2015","unstructured":"Lee KM, Nam K, Oh S, Lim J, Kim RK, Shim D, et al. ECM1 regulates tumor metastasis and CSC-like property through stabilization of \u03b2-catenin. Oncogene. 2015;34:6055\u201365.","journal-title":"Oncogene"},{"key":"2276_CR25","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1182\/blood-2005-12-028456","volume":"108","author":"KJ Aichberger","year":"2006","unstructured":"Aichberger KJ, Mayerhofer M, Vales A, Krauth MT, Gleixner KV, Bilban M, et al. The CML-related oncoprotein BCR\/ABL induces expression of histidine decarboxylase (HDC) and the synthesis of histamine in leukemic cells. Blood. 2006;108:3538\u201347.","journal-title":"Blood"},{"key":"2276_CR26","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.ccell.2019.03.005","volume":"35","author":"N Luong-Gardiol","year":"2019","unstructured":"Luong-Gardiol N, Siddiqui I, Pizzitola I, Jeevan-Raj B, Charmoy M, Huang Y, et al. \u03b3-Catenin-Dependent Signals Maintain BCR-ABL1+ B Cell Acute Lymphoblastic Leukemia. Cancer Cell. 2019;35:649\u201363.","journal-title":"Cancer Cell"},{"key":"2276_CR27","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1182\/bloodadvances.2021005955","volume":"6","author":"T Pieters","year":"2022","unstructured":"Pieters T, Almeida A, T\u2019Sas S, Lemeire K, Hochepied T, Berx G, et al. Myb drives B-cell neoplasms and myeloid malignancies in vivo. Blood Adv. 2022;6:2987\u201391.","journal-title":"Blood Adv"},{"key":"2276_CR28","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1182\/blood-2017-10-813576","volume":"131","author":"F Wang","year":"2018","unstructured":"Wang F, Demir S, Gehringer F, Osswald CD, Seyfried F, Enzenm\u00fcller S, et al. Tight regulation of FOXO1 is essential for maintenance of B-cell precursor acute lymphoblastic leukemia. Blood. 2018;131:2929\u201342.","journal-title":"Blood"},{"key":"2276_CR29","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1074-7613(02)00269-8","volume":"16","author":"RP DeKoter","year":"2002","unstructured":"DeKoter RP, Lee HJ, Singh H. PU.1 Regulates Expression of the Interleukin-7 Receptor in Lymphoid Progenitors. Immunity. 2002;16:297\u2013309.","journal-title":"Immunity"},{"key":"2276_CR30","doi-asserted-by":"publisher","first-page":"26267","DOI":"10.1074\/jbc.R111.252569","volume":"286","author":"S Iyengar","year":"2011","unstructured":"Iyengar S, Farnham PJ. KAP1 protein: An enigmatic master regulator of the genome. J Biol Chem. 2011;286:26267\u201376.","journal-title":"J Biol Chem"},{"key":"2276_CR31","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/ncb1618","volume":"9","author":"A Zippo","year":"2007","unstructured":"Zippo A, De Robertis A, Serafini R, Oliviero S. PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation. Nat Cell Biol. 2007;9:932\u201344.","journal-title":"Nat Cell Biol"},{"key":"2276_CR32","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1016\/j.celrep.2019.10.098","volume":"29","author":"E S\u00f8ndergaard","year":"2019","unstructured":"S\u00f8ndergaard E, Rauch A, Michaut M, Rapin N, Rehn M, Wilhelmson AS, et al. ERG Controls B Cell Development by Promoting Igh V-to-DJ Recombination. Cell Rep. 2019;29:2756\u201369.","journal-title":"Cell Rep"},{"key":"2276_CR33","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1038\/ng.3691","volume":"48","author":"J Zhang","year":"2016","unstructured":"Zhang J, McCastlain K, Yoshihara H, Xu B, Chang Y, Churchman ML, et al. Deregulation of DUX4 and ERG in acute lymphoblastic leukemia. Nat Genet. 2016;48:1481\u20139.","journal-title":"Nat Genet"},{"key":"2276_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.molcel.2013.08.037","volume":"52","author":"J Gertz","year":"2013","unstructured":"Gertz J, Savic D, Varley KE, Partridge EC, Safi A, Jain P, et al. Distinct properties of cell-type-specific and shared transcription factor binding sites. Mol Cell. 2013;52:25\u201336.","journal-title":"Mol Cell"},{"key":"2276_CR35","doi-asserted-by":"publisher","first-page":"5531","DOI":"10.1128\/MCB.15.10.5531","volume":"15","author":"D Cortez","year":"1995","unstructured":"Cortez D, Kadlec L, Pendergast AM. Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis. Mol Cell Biol. 1995;15:5531\u201341.","journal-title":"Mol Cell Biol"},{"key":"2276_CR36","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1182\/blood-2002-01-0043","volume":"101","author":"C Schuster","year":"2003","unstructured":"Schuster C, Forster K, Dierks H, Els\u00e4sser A, Behre G, Simon N, et al. The effects of Bcr-Abl on C\/EBP transcription-factor regulation and neutrophilic differentiation are reversed by the Abl kinase inhibitor imatinib mesylate. Blood. 2003;101:655\u201363.","journal-title":"Blood"},{"key":"2276_CR37","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s11033-019-05123-9","volume":"47","author":"X Jiang","year":"2020","unstructured":"Jiang X, Xie H, Dou Y, Yuan J, Zeng D, Xiao S. Expression and function of FRA1 protein in tumors. Mol Biol Rep. 2020;47:737\u201352.","journal-title":"Mol Biol Rep"},{"key":"2276_CR38","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nm.4310","volume":"23","author":"M Kesarwani","year":"2017","unstructured":"Kesarwani M, Kincaid Z, Gomaa A, Huber E, Rohrabaugh S, Siddiqui Z, et al. Targeting c-FOS and DUSP1 abrogates intrinsic resistance to tyrosine-kinase inhibitor therapy in BCR-ABL-induced leukemia. Nat Med. 2017;23:472\u201382.","journal-title":"Nat Med"},{"key":"2276_CR39","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/nar\/29.2.397","volume":"29","author":"M Schuhmacher","year":"2001","unstructured":"Schuhmacher M, Kohlhuber F, H\u00f6lzel M, Kaiser C, Burtscher H, Jarsch M, et al. The transcriptional program of a human B cell line in response to Myc. Nucleic Acids Res. 2001;29:397\u2013406.","journal-title":"Nucleic Acids Res"},{"key":"2276_CR40","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1101\/gad.1067003","volume":"17","author":"PC Fernandez","year":"2003","unstructured":"Fernandez PC, Frank SR, Wang L, Schroeder M, Liu S, Greene J, et al. Genomic targets of the human c-Myc protein. Genes Dev. 2003;17:1115\u201329.","journal-title":"Genes Dev"},{"key":"2276_CR41","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/ng1361","volume":"36","author":"F Rosenbauer","year":"2004","unstructured":"Rosenbauer F, Wagner K, Kutok JL, Iwasaki H, Le Beau MM, Okuno Y, et al. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat Genet. 2004;36:624\u201330.","journal-title":"Nat Genet"},{"key":"2276_CR42","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.molcel.2013.01.007","volume":"49","author":"PB Staber","year":"2013","unstructured":"Staber PB, Zhang P, Ye M, Welner RS, Nombela-Arrieta C, Bach C, et al. Sustained PU.1 Levels Balance Cell-Cycle Regulators to Prevent Exhaustion of Adult Hematopoietic Stem Cells. Mol Cell. 2013;49:934\u201346.","journal-title":"Mol Cell"},{"key":"2276_CR43","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.brainres.2018.02.043","volume":"1705","author":"DA Grassi","year":"2019","unstructured":"Grassi DA, J\u00f6nsson ME, Bratt\u00e5s PL, Jakobsson J. TRIM28 and the control of transposable elements in the brain. Brain Res. 2019;1705:43\u20137.","journal-title":"Brain Res"},{"key":"2276_CR44","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41586-021-03542-y","volume":"596","author":"V Gorbunova","year":"2021","unstructured":"Gorbunova V, Seluanov A, Mita P, McKerrow W, Feny\u00f6 D, Boeke JD, et al. The role of retrotransposable elements in ageing and age-associated diseases. Nature. 2021;596:43\u201353.","journal-title":"Nature"},{"key":"2276_CR45","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.stemcr.2013.12.008","volume":"2","author":"S Miyagi","year":"2014","unstructured":"Miyagi S, Koide S, Saraya A, Wendt GR, Oshima M, Konuma T, et al. The TIF1\u03b2-HP1 system maintains transcriptional integrity of hematopoietic stem cells. Stem Cell Rep. 2014;2:145\u201352.","journal-title":"Stem Cell Rep"},{"key":"2276_CR46","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1182\/blood-2003-12-4369","volume":"105","author":"S Koschmieder","year":"2005","unstructured":"Koschmieder S, G\u00f6ttgens B, Zhang P, Iwasaki-Arai J, Akashi K, Kutok JL, et al. Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis. Blood. 2005;105:324\u201334.","journal-title":"Blood"},{"key":"2276_CR47","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","volume":"172","author":"J Mestas","year":"2004","unstructured":"Mestas J, Hughes CCW. Of Mice and Not Men: Differences between Mouse and Human Immunology. J Immunol. 2004;172:2731\u20138.","journal-title":"J Immunol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-024-02276-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-024-02276-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-024-02276-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T12:07:41Z","timestamp":1717416461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-024-02276-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,11]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["2276"],"URL":"https:\/\/doi.org\/10.1038\/s41375-024-02276-w","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,11]]},"assertion":[{"value":"4 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}